Product Information
TAZAROTENE 0.1% CREAM is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $1.9245 per GM under NDC 00713067031. Its NADAC has been published 445 times since Mar 28, 2018.
FDA first approved this application on Dec 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713067031
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TAZAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA208662FDA Approved
12/22/2017
TE Code
AB
On Market Since
12/22/2017
Pharmacological Classes
Price Statistics
The NADAC for TAZAROTENE 0.1% CREAM has been published 445 times since Mar 28, 2018, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9245 per GM |
|---|---|
| All-time high | $8.1719 (Sep 12, 2018) |
| All-time low | $1.4726 (Jul 17, 2024) |
| 52-week high | $2.3074 |
| 52-week low | $1.8023 |
| Median price | $2.9715 |
| Average price | $3.2345 |
| Largest weekly change | +58.0% (Aug 22, 2018) |
| Weeks tracked | 445 |
| Tracking since | Mar 28, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tazarotene market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAZAROTENE 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.1% CREAM, manufactured by Cosette Pharmaceuticals, Inc., is $1.9245 per GM (NDC 00713067031), effective Sep 30, 2026.
How has the price of TAZAROTENE 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for TAZAROTENE 0.1% CREAM has declined 73.4%. It has been tracked across 445 weekly CMS publications since Mar 28, 2018.
What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.1% CREAM?
Since Mar 28, 2018, the NADAC for TAZAROTENE 0.1% CREAM has ranged from a low of $1.4726 (Jul 17, 2024) to a high of $8.1719 (Sep 12, 2018), with a median of $2.9715 per GM.
Are there cheaper alternatives to TAZAROTENE 0.1% CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TAZAROTENE 0.1% CREAM, is $1.8492 per GM — about 4% below TAZAROTENE 0.1% CREAM.
Who manufactures TAZAROTENE 0.1% CREAM?
TAZAROTENE 0.1% CREAM (NDC 00713067031) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.